The Lactose-Free Shelf Is a Protein Business Wearing an Intolerance Label

One aisle, two growth rates

In the 52 weeks to 13 July 2025, lactose-free yogurt sold through US retail grew 41% in dollars and 40.7% in volume. The figures are Circana’s, reported by Dairy Foods, and they sit inside a wider lactose-free dairy set that grew 8.5% in dollars and 3.8% in volume across the fifteen categories Circana tracks. Lactose-free milk: 8.2% in dollars, 3.8% in volume. Lactose-free sour cream: 12% and 14.1%. Lactose-free cottage cheese: 30.8% and 29.9%.

Milk is the larger lactose-free business by a distance. Yogurt is the fastest one. Set the 41% against the total US yogurt category — up 11.6% in dollars for the 52 weeks to 20 April 2025 and 14% by year-end 2025 — and the lactose-free line is growing at roughly 2.9 times the category rate.

Then set it against the shape of American dairy demand and the number stops behaving like a normal category. All lactose-free dairy together is 4.6% of Dairy15 sales. The prevalence figure normally put beside it is 36% — the share of Americans with lactose malabsorption, per the National Institute of Diabetes and Digestive and Kidney Diseases, against roughly 68% globally. Prevalence runs at nearly eight times the shelf share.

That gap can be read as headroom or as a warning, and the reading decides how a company competes. If it is headroom, the play is distribution and education: get lactose-free yogurt in front of the 36%. If it is a warning, the play is something else entirely — because the buyer was never shopping for the words “lactose free”. They were shopping for something the dairy case has only recently learned to sell well, and the intolerance claim came along for the ride.

Two ways to take the lactose out, and only one of them is a lactose strategy

Lactase hydrolysis is the obvious route. The enzyme splits lactose into glucose and galactose, both sweeter and easier to digest, and the product keeps its water and its minerals. It is a compliance step with a cost per litre and no other benefit. Nothing else on the pack changes.

Filtration is the other route, and it works by subtraction. Ultrafiltration passes lactose, water and dissolved minerals through a membrane while retaining protein and calcium; the retentate is denser in protein and effectively lactose-free. Traditional Greek straining does something similar with a cloth or a centrifuge: lactose leaves with the whey, and what stays behind is thicker and higher in protein.

Both produce a product that may carry the same lactose-free claim. They produce completely different businesses. Hydrolysis defends a customer who has already decided to avoid lactose. Filtration creates a product that is worth more per ounce for reasons that have nothing to do with lactose at all — and the lactose-free claim is thrown in.

Ultrafiltration is the tell

Ultrafiltered milk carries roughly 50% more protein and 50% less sugar than regular milk, and it is lactose-free as a consequence of how it is made. Circana’s read on the segment: it accounts for 7% of total milk dollars while growing 14.8% in dollars and 5.5% in units over the past year. fairlife holds 96% of ultrafiltered dollars. Darigold FIT is the second player and more than doubled in the year. Private label is up 20%. fairlife sells at a 190% premium per ounce against regular whole milk at Walmart.

Now the sentence that explains this article. Circana’s Melissa Altobelli says the ultrafiltration process is being leveraged in yogurt as well, naming Danone’s Two Good and Oikos Pro.

The formulator’s decision, in other words, is not “make a lactose-free yogurt”. It is “hit fifteen or twenty grams of protein per serving without adding a powder”. Lactose removal arrives with the protein, at no additional process cost, and the brand then has a free choice about what to put on the front of the pack: the protein number, the lactose-free claim, or both. The claim that grew 41% is not the reason the product was made.

Chobani’s newest range makes the choice visible

Chobani 20G, launched in Australia in April 2026, delivers 20 grams of protein per serve by straining fresh milk further, with no milk powders, no added sugar and no artificial sweeteners. The company’s own description of the product includes the phrase “remaining lactose free” — as a property of the straining process, listed among the things the process preserves rather than as the proposition.

The pitch is protein and ingredient simplicity: real food, no powders. That is the template. Where the process is the story, lactose-free is a footnote; where the process is absent, lactose-free is the whole story and it sells to a fraction of the market.

The category’s centre of gravity moved to drinks and to protein

US yogurt reached USD 11.8 billion in dollar sales for the 52 weeks to 20 April 2025, up 11.6% on the prior year, with unit sales up 7%. By year-end 2025 Circana had the category at USD 12.8 billion, up 14% in dollars, with refrigerated yogurt drinks — the drinkables — growing 24% in dollars and 16% in units, ahead of spoonable.

Concentration is high at the top and unusually fragmented underneath. NielsenIQ puts Danone at 28.2% of US yogurt sales and Chobani at 22.3%. But Hispanic brands — LaLa, El Mexicano, Nuestro and La Ricura — together account for roughly 31% of yogurt sales on Evidnt’s numbers, a bloc larger than any single legacy brand in the market. That is a category where the shelf is not one conversation.

Protein changes the unit economics in a way that matters more than the share table. The same 5.3-ounce cup carrying 20 grams instead of 12 is the same cup, the same cold chain, the same shelf space and the same truck — and a higher price. Growth of that kind shows up in dollars and volume at the same time rather than in dollars bought with discount. It is the only kind of growth worth having in a mature category.

Who actually earns the 41%

Three things follow from the mechanism, and they are the basis on which this segment should be judged.

The asset is the membrane and the straining line, not the claim. A lactase dose is a purchased input any co-packer can buy. A filtration train is capital, water, cleaning cycles, yield loss and a curve of process know-how. That is a defensible position; the word “lactose free” on a lid is not.

The claim is copyable, and it is being copied. Private label grew 20% in ultrafiltered milk in a year, and Darigold’s FIT line more than doubled from a small base. Both are signals that the arbitrage between “cost of the process” and “price of the claim” is narrowing.

The premium is a proxy for protein, and it survives as long as the protein number is scarce. fairlife at 190% per ounce over regular whole milk is not a lactose premium. It is a protein-and-sugar premium attached to a brand that got there first with a process, and every entrant that reaches the same protein number at a lower price becomes the reference.

What the numbers do not say

Circana does not publish a dollar base for lactose-free yogurt. The 4.6% share figure covers all lactose-free dairy. Any specific US lactose-free yogurt market size in circulation is an inference from category totals and a growth rate, and should be treated as such — including any figure you see quoted confidently.

Malabsorption is not intolerance, and intolerance is not purchase. A person with reduced lactase activity can eat yogurt, particularly a strained one, and a person with no clinical issue at all can buy lactose-free because it is the high-protein cup on the shelf. The 36% and the 4.6% are measuring two different populations.

Finally, the frame. Pheonix Research values the global yogurt market at USD 115.4 billion in 2025, rising to USD 168.9 billion by 2033 at a compound annual growth rate of about 4.9%, with Europe the largest region and Asia-Pacific the fastest growing and Greek and high-protein yogurt the leading product segment. A 41% line in the United States is a share shift inside a mid-single-digit global category. It is a very good business to be in. It is not a new market, and the companies that treat it as one will build capacity for a demand curve that is really a migration.

What to watch

• Whether 40% volume growth survives a second year. Growth rates of this size off a small base revert. The test is whether lactose-free yogurt holds a double-digit share of category units once the base has doubled.
• Private label’s share of the lactose-free shelf. It is the cleanest measure of how much of the premium is process and how much is brand.
• Protein per dollar, not lactose-free per dollar. The competitive axis is converging on grams of protein per cent spent, and lactose-free is being absorbed into it.
• GLP-1 prescribing. Circana ties the protein surge directly to GLP-1 use, and the mechanism — higher protein, lower sugar, digestible dairy — is the same one that produces lactose-free as a by-product.
• Whether “lactose free” stays a premium claim. Once filtration is standard equipment in a category, a claim that comes free with the process has a limited life as a price differentiator.